The IZB normally hosts monthly network meetings with top researchers from the Martinsried campus and the biotech start-ups at the IZB. The Biotech Press Lounge with 100 guests from the biotech, pharmaceutical and venture capital sectors has also been held three times a year. Due to the distance rules in Corona times, all events are canceled until November 2020. The first IZBrunch is scheduled for November 26, 2020. The Biotech Press Lounge is currently on hold.
“The IZB provides our team the perfect environment to kick-start our projects and operations and we are grateful to be part of this community.”
Dr. Adrian Schomburg, CEO & Founder
“Pets make a difference in our life; we should make a difference in theirs. Therefore, we are glad for the opportunity to be the first company at IZB with a veterinary focus.”
Dr. Kathrin Ladetzki-Baehs, Managing Director
“Before founding Bind-X, we evaluated 5 biotech clusters in 4 European countries. The decision in favor of the IZB was the right one and clearly contributed to our success.”
Martin Spitznagel, CEO & Founder
“With its strategic location on the Martinsried campus, the IZB offers an outstanding opportunity to found a company in the vicinity of science and industry.”
Dr. Moritz Völker-Albert, Managing Director
“As part of the IZB family we have access to a great location and an excellent start-up network.”
Dr. Garwin Pichler, CEO, Dr. Nils Kulak, CEO, PreOmics GmbH